Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SANTHERA PHARMACEUTICALS HOLDING AG

(SANN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s products include Catena and Raxone brands, which are primarily implemented in the symptomatic treatment of Leber's Hereditary Optic Neuropathy (LHON) diseases. Sathera Pharmaceuticals Holding AG operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Number of employees : 91 people.
Sales per Business
20192020Delta
CHF (in Million)%CHF (in Million)%
Pharmaceutical Products75.38100%15.01100% -80.09%
Sales per region
20192020Delta
CHF (in Million)%CHF (in Million)%
European Union75.1899.7%15.00100% -80.05%
Rest of the World0.1960.3%0.0070% -96.43%
Managers
NameAgeSinceTitle
Dario Eklund522019Chief Executive Officer
Andrew P. Smith, Dr.572020Chief Financial Officer
Martin Gertsch562017Vice Chairman
Philipp Gutzwiller522017Independent Director
Elmar J. Schnee, Dr.612017Chairman
Patrick Volkert Vink, Dr.562017Independent Director
Oliver Strub572006Secretary, Executive VP & General Counsel
Günther Metz, Dr.622004Senior Vice President-Business Development
Members of the board
NameAgeSinceTitle
Elmar J. Schnee, Dr.612017Chairman
Thomas Meier, Dr.582019Director
Martin Gertsch562017Vice Chairman
Philipp Gutzwiller522017Independent Director
Patrick Volkert Vink, Dr.562017Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,201,136 21,748,528 83.0% 1,301,075 5.0% 83.0%
Shareholders
NameEquities%
Santhera Pharmaceuticals Holding AG 2,093,242 7.28%
OrbiMed Advisors LLC 1,712,000 5.95%
Idorsia Pharmaceuticals Ltd. 1,700,000 5.91%
Ernesto Bertarelli 708,941 2.46%
TOBAM SAS 172,459 0.60%
Zürcher Kantonalbank (Investment Management) 139,484 0.48%
Credit Suisse Asset Management (Schweiz) AG 139,268 0.48%
Thomas Meier 82,902 0.29%
UBS Asset Management Switzerland AG 81,050 0.28%
Rieter Fischer Partners AG 50,798 0.18%
Holdings
NameEquities%Valuation
Santhera Pharmaceuticals Holding AG (SANN) 2,093,2427.28%4,748,101 USD
Company contact information
Santhera Pharmaceuticals Holding AG
Hohenrainstrasse 24
Pratteln, Basel-Landschaft (Basle Country) 4133

Phone : +41.61.906.89.50
Fax : +41.61.906.89.51
Web : http://www.santhera.com